Talphera (TLPH) Total Current Liabilities (2010 - 2026)

Talphera's (TLPH) quarterly Total Current Liabilities came in at $4.0 million in Q1 2026, up 102.36% year-on-year from $2.0 million in Q1 2025, and up 5.67% quarter-over-quarter from $3.8 million in Q4 2025.

Talphera (TLPH) Total Current Liabilities (2010 - 2026) Analysis & Trends

Talphera's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $4.0 million for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 102.36% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 102.36% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, up 43.9% from the prior year.
  • Total Current Liabilities advanced to $4.0 million in Q1 2026 per TLPH's latest filing, from $3.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $17.7 million in Q2 2022 and bottomed at $2.0 million in Q1 2025.
  • The 5-year median for Total Current Liabilities is $3.8 million (2025), against an average of $6.7 million.
  • Across the five-year window, Total Current Liabilities plunged 77.16% in 2023 and surged 102.36% in 2026, its largest moves.
  • Year by year, Total Current Liabilities stood at $13.8 million in 2022, then plunged by 67.23% to $4.5 million in 2023, then slumped by 41.33% to $2.6 million in 2024, then surged by 43.9% to $3.8 million in 2025, then advanced by 5.67% to $4.0 million in 2026.
  • Per Business Quant, the three latest TLPH Total Current Liabilities figures stand at $4.0 million (Q1 2026), $3.8 million (Q4 2025), and $3.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Talphera 47.31 Mn 9.48 Mn - 4.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.03 Mn
Dec 31, 2025 3.81 Mn
Sep 30, 2025 3.21 Mn
Jun 30, 2025 2.63 Mn
Mar 31, 2025 1.99 Mn
Dec 31, 2024 2.65 Mn
Sep 30, 2024 2.76 Mn
Jun 30, 2024 3.27 Mn
Mar 31, 2024 3.34 Mn
Dec 31, 2023 4.51 Mn
Sep 30, 2023 3.57 Mn
Jun 30, 2023 4.22 Mn
Mar 31, 2023 9.46 Mn
Dec 31, 2022 13.77 Mn
Sep 30, 2022 15.65 Mn
Jun 30, 2022 17.69 Mn
Mar 31, 2022 17.03 Mn
Dec 31, 2021 18.51 Mn
Sep 30, 2021 17.07 Mn
Jun 30, 2021 15.19 Mn